Spatially fractionated radiation therapy for locally advanced cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a special type of radiation therapy called spatially fractionated radiation therapy for cervical cancer that has grown large but hasn't spread far. It aims to make the radiation more effective while protecting healthy tissue, and is given alongside standard chemotherapy and radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You have been diagnosed with cervical cancer (confirmed by biopsy).
- Your cancer is at a locally advanced stage (stage IIB to IVA) and the tumor is at least 4 cm (about 1.6 inches) in size.
- You are in reasonably good health (able to care for yourself and up and about more than 50% of waking hours).
- You are planning to receive standard treatment that combines chemotherapy and radiation.
- You are not pregnant and, if you could become pregnant, you agree to use effective birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special type of radiation that is given in small, spaced-out beams to treat gynecologic cancers (like cervical or uterine cancer). It is for patients who cannot get standard internal radiation (brachytherapy) because of unusual anatomy, large tumors, a narrow vagina, or anesthesia risks.
This study tests a combination of two chemotherapy drugs (nab-paclitaxel and cisplatin) given alongside radiation therapy for people with locally advanced cervical cancer. The goal is to see if this combination is safe and effective in shrinking the cancer and improving outcomes.
This trial tests a type of radiation that adapts to your body changes during treatment for cervical cancer. It aims to improve accuracy and reduce side effects.
This trial tests a new way of giving radiation therapy for cervical cancer that uses higher doses in fewer treatments. Researchers want to see if this faster approach works as well as standard radiation while reducing side effects and treatment time.
This trial tests a feasibility (“can it be done safely?”) approach that delivers radiation in a shorter schedule for some cervical cancer patients. It also uses weekly cisplatin chemotherapy and includes a radiation procedure called brachytherapy to improve treatment effectiveness.
This trial tests a shorter course of high-precision radiation therapy given at the same time as chemotherapy for cervical cancer that has not spread to distant organs. It aims to find if this approach is effective and safe for patients with locally advanced disease.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.